rHuEPO once/week vs rHuEPO
Adverse events associated with transfusion · patients with the anaemia of end‐stage kidney disease undergoing dialysis
1 finding from 1 review
- Frequency of administration of erythropoiesis‐stimulating agents for the anaemia of end‐stage kidney disease in… 2014 · Cochrane Headline outcomes onlyno estimate extracted1 study · 173 participantsGRADE not reported